Depression is a common mental disorder. Some 300 million people in the world have it, or an estimated 3.8% of the population, ...

A University of Queensland-led team analyzed data for 204 countries and territories, to assess global access to adequate ...

Major depressive disorder (MDD), commonly referred to as depression, is a serious medical condition that affects a person's ...

Psilocybin effects on depression and anxiety are generally safe and well-tolerated, but researchers should focus on determining optimal dosage.

In contrast to electroconvulsive therapy, patients are not sedated during the treatments. Studies of a protocol called ...

Discover how combining brain stimulation therapies improves depression treatment outcomes compared to single therapies, ...

Bright light therapy improves remission and response rates in nonseasonal depression, enhances antidepressant effectiveness, ...

A study published in the Journal of Affective Disorders proposes a novel, fully automated artificial intelligence (AI) ...

Cybin, Inc. ( (CYBN) ) has released its Q2 earnings. Here is a breakdown of the information Cybin, Inc. presented to its investors.Don't Miss ...

Researchers have found 70 per cent of Australians diagnosed with major depressive disorder are not receiving even the minimal treatment necessary.

Researchers have found 70 per cent of Australians diagnosed with major depressive disorder are not receiving even the minimal treatment necessary.A ...

We are highly encouraged that our approach to treating MDD patients with two 16 mg doses of CYB003, three weeks apart, has demonstrated consistent, robust and sustained treatment benefits through to ...